Turmeric for Patients With Basal Joint Arthritis

Part of paid clinical trials in Boston, Massachusetts.

Sponsor
Massachusetts General Hospital
Study ID
NCT03017118
Status
Recruiting
Apply to this trial

Conditions

  • Thumb Osteoarthritis

Eligibility Criteria

Sex
ALL
Age
40 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Turmeric — DIETARY_SUPPLEMENT
    Subjects will receive turmeric (100 mg pastille) 3 times per day for 6 weeks.
  • Placebo — OTHER
    Subjects in the control group will receive a placebo 3 times per day for 6 weeks.

Study Details

The aim of this study is to assess whether the use of a commercially available nutraceutical, turmeric, is an effective option to manage pain and stiffness in patients with basal joint arthritis. To conduct a pilot Randomized Controlled Trial evaluating the impact of turmeric on basal joint arthritis.

Key Dates

Start date
Aug 9, 2017
Status verified
Nov 2025
Primary completion
Dec 31, 2027
Completion
Jan 31, 2028

Study Design

Enrollment
60 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: Turmeric
    Subjects in this group will receive turmeric (100 mg pastille) 3 times per day for 6 weeks.
  • Placebo Comparator: Control
    Subjects in this group will receive a placebo pill 3 times per day for 6 weeks.

Primary Outcome Measure

Change in baseline pain intensity [ Time Frame: Enrollment, 6 weeks, and 3 months ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Massachusetts General HospitalBostonMassachusetts02114
Neal Chen, MD
[email protected]
617-726-4700
Kiera Lunn, BSc
[email protected]
6177261569

Find similar trials in Boston, MA

By research site
Massachusetts General Hospital· Boston, MA

Related Studies